How can I get hep C treatment for free?

How can I get hep C treatment for free?

These are some of the nonprofit groups that offer assistance:

1. Good Days.
2. HealthWell Foundation.
3. The Hepatitis C Association: Help4Hep.
4. Patient Access Network Foundation.
5. Patient Advocate Foundation Co-Pay Relief Program.
6. The Assistance Fund.
7. Patient Services, Inc.

How does Gilead advancing access work?

Gilead’s Advancing Access is a patient assistance program. Gilead offers financial support to men and women prescribed a Gilead Science medication. The program assists insured, uninsured, and under-insured patients that may not afford the prescribed drug.

Does insurance pay for Epclusa?

99% of Medicaid patients taking EPCLUSA or its Authorized Generic pay $5 or less per co-pay. Patients who are dual-eligible may be covered through their Medicare benefit and pay $9.85 or less per co-pay.

How expensive is it to cure hep C?

The cost of hep C treatment varies depending on the type of drug. However, an 8- to 12-week course can range from $54,000 to $95,000 (or higher). For example, the price of a 12-week course of Zepatier can be as much as $54,600, and a 12-week course of Harvoni can cost as much as $94,500.

Does Gilead co-pay card expire?

Have no fear, the cards are not expired, and you can still fill your PrEP prescription. Gilead has updated their RxBIN, RxPCN, RxGRP, and anyone who previously had a 9-digit Member ID now has a new 11 digit Member ID.

Does Gilead cover Descovy?

If you have commercial insurance The Gilead Advancing Access co-pay coupon card might help you save. If you are commercially insured and eligible, the co-pay coupon card covers up to $7,200 in co-pays per year with no monthly limit for DESCOVY for PrEP. For some people, that could mean paying as little as a $0 co-pay.

Is Epclusa brand or generic?

In January 2019, Asegua Therapeutics, a subsidiary of Gilead Sciences, launched authorized generic versions of Gilead’s Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) tablets. Generic Epclusa was launched January 7, 2019 and generic Harvoni will launch late January.

What is Gilead doing to treat viral hepatitis?

Gilead has developed today’s leading medicines for viral hepatitis. Gilead is working with regional partners to introduce branded Sovaldi ®, Harvoni ® and Epclusa ® in low- and middle-income countries, prioritizing those with the greatest disease burden.

How can I get financial support for Gilead HCV and HBV medications?

Support Path patient assistance program, which provides Gilead HCV and HBV medicines at no cost for qualified patients who meet the program’s eligibility criteria. The Zydelig AccessConnect program helps patients understand their coverage and identify financial support options to access Zydelig ® (idelalisib). The program offerings include:

Where can I get help with Gilead treatment?

Support Path We’re here to help. Support Path is a program that can help patients get started on Gilead and Asegua treatments. Call now to connect live with a Support Path Program Navigator at

How do I contact Gilead advancing access?

Providing coding and reimbursement information. To learn more about the Advancing Access program, visit www.GileadAdvancingAccess.com or call 1-800-226-2056, Monday through Friday between 9 a.m. and 8 p.m. EST.